Current Report Filing (8-k)
September 05 2014 - 5:24PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): September 5, 2014
NANOVIRICIDES, INC. |
(Exact name of registrant as specified in its charter) |
Nevada |
001-36081 |
76-0674577 |
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(I.R.S. Employer
Identification No.) |
135 Wood Street, Suite 205
West Haven, Connecticut |
06516 |
(Address of principal executive offices) |
(Zip Code) |
(203) 937-6137 |
(Registrant’s telephone number, including area code) |
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On September 5, 2014, NanoViricides, Inc.
(the “Registrant”) accepted notices to exercise warrants for the purchase of an aggregate of 2,136,655 shares of the
Registrant’s common stock at the exercise price of $3.50 per share for aggregate proceeds of $7,478,292.50. On July 17, 2014,
the Registrant filed a registration statement on Form S-3 (the “Form S-3”) registering an aggregate of 3,071,986 shares
of common stock underlying warrants previously issued by the Registrant in various private placement offerings between 2005 and
September 2009, as described more fully in the Form S-3 (the “Registered Warrants”). The Form S-3 was declared effective
by the Securities and Exchange Commission on August 1, 2014. As of August 15, 2014, any Registered Warrants as specified above
and not previously exercised have expired.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
NANOVIRICIDES, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
Date: September 5, 2014 |
|
By: |
/s/ Eugene Seymour |
|
|
|
|
|
Name: Eugene Seymour |
|
|
|
|
|
Title: Chief Executive Officer |
|
NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Jul 2023 to Jul 2024